Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
20%
OVERLAP
BY WEIGHT
16
# OF OVERLAPPING
HOLDINGS
IBBQ
207
HOLDINGS
8%
ALSO IN MEDX
MEDX
28
HOLDINGS
57%
ALSO IN IBBQ
SECTOR DRIFT (IBBQ minus MEDX)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBBQ |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
ALNYLAM PHARMACEUTICALS INC | 5.3% | 6.1% | 5.3% |
 |
ASTRAZENECA PLC-SPONS ADR | 3.9% | 5.1% | 3.9% |
|
AMGEN INC | 7.6% | 3.7% | 3.7% |
|
REGENERON PHARMACEUTICALS | 5.5% | 2.2% | 2.2% |
|
BIOGEN IDEC INC | 2.1% | 2.5% | 2.1% |
IBBQ Overweight Relative to MEDX
|
VERTEX PHARMACEUTICALS INC | 7.6% |
|
GILEAD SCIENCES INC | 7.4% |
|
AMGEN INC | 4.0% |
|
REGENERON PHARMACEUTICALS | 3.3% |
|
INSMED INC | 3.0% |
 |
ARGENX SE ADR | 2.2% |
|
UNITED THERAPEUTICS CORP | 1.8% |
|
INCYTE CORP | 1.5% |
|
SUMMIT THERAPEUTICS INC | 1.4% |
|
ILLUMINA INC | 1.4% |
IBBQ Underweight Relative to MEDX
|
ELI LILLY & CO | -14.8% |
|
ABBVIE INC | -9.3% |
 |
NOVARTIS AG-ADR | -6.7% |
|
JOHNSON & JOHNSON | -4.9% |
|
BRISTOL-MYERS SQUIBB CO | -3.9% |
|
IONIS PHARMACEUTICALS, INC. | -3.7% |
|
PFIZER INC | -3.4% |
|
CRISPR THERAPEUTICS AG | -3.3% |
 |
ALKERMES PLC | -3.2% |
|
MERCK & CO. INC. | -3.1% |